Welcome to Crene Biotechnology!

+86-576-88205808

Product :

GHRP-6

GHRP-6  87616-84-0
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:GHRP-6 Purity:98% min
CAS NO:87616-84-0 Solubility:Soluble in DMSO
Molecular Formula:C46H56N12O6 Package:Package according to customer requirements
Molecular Weight:873.014 Storage:Store at -20℃
Quality control
Remarks

GH-releasing peptides (GHRPs) are synthetic peptides that like GHRH act directly on pituitary somatotrophs to stimulate GH release. Growth hormone (GH) release is stimulated by a variety of synthetic secretagogues, of which growth hormone-releasing hexapeptide (GHRP-6) has been most thoroughly studied; it is thought to have actions at both pituitary and hypothalamic site. 

 

Synonyms:

GH-Releasing peptide;

GH-Releasing hexapeptide 6;

His(1)-lys(6)-ghrp;

Growthhormonereleasingpeptide;

growth hormone releasing hexapeptide;

GHRP-6 Acetate;


Properties:
Density: 1.333g/cm3
Boiling Point: 1407ºC at 760 mmHg
Flash Point: 804.7ºC
Refractive Index: 1.664

 

 

 

Related Prodcuts:

Tripeptide-1; Prezatide copper acetate; Tetrapeptide-30; Myristoyl tetrapeptide-12; Pentapeptide-3; Melitane Nonapeptide-1; Decapeptide-12; Acetyl tetrapeptide-3; Syn-Ake acetate; Pralmorelin

References

1: Klein K, Yang J, Aisenberg J, Wright N, Kaplowitz P, Lahlou N, Linares J, Lundström E, Purcea D, Cassorla F. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty. J Pediatr Endocrinol Metab. 2016 Feb 17. pii: /j/jpem.ahead-of-print/jpem-2015-0376/jpem-2015-0376.xml. doi: 10.1515/jpem-2015-0376. [Epub ahead of print] PubMed PMID: 26887034.

2: Meattini I, Saieva C, Meacci F, Scotti V, De Luca Cardillo C, Desideri I, Baldazzi V, Mangoni M, Scoccianti S, Detti B, Simontacchi G, Nori J, Orzalesi L, Sanchez L, Casella D, Bernini M, Fambrini M, Bianchi S, Livi L. Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin. Future Oncol. 2016 Mar;12(5):625-35. doi: 10.2217/fon.15.357. Epub 2016 Feb 3. PubMed PMID: 26837239.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China